PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23272250-7	2012	Quantitative chromatin immunoprecipitation-PCR (ChIP-qPCR) shows that treatment with valproic acid (VPA) increases the recruitment of Kdm5a and Kdm6a to proximal promoter (PP) and proximal enhancer (PE) of Pou5f1 whereas enrichment of Ep300 and Kdm6b was seen in PP but not PE of Pou5f1 promoter.	Valproic Acid	85-98	E1A binding protein p300	Mus musculus	235-240	
23272250-7	2012	Quantitative chromatin immunoprecipitation-PCR (ChIP-qPCR) shows that treatment with valproic acid (VPA) increases the recruitment of Kdm5a and Kdm6a to proximal promoter (PP) and proximal enhancer (PE) of Pou5f1 whereas enrichment of Ep300 and Kdm6b was seen in PP but not PE of Pou5f1 promoter.	Valproic Acid	100-103	E1A binding protein p300	Mus musculus	235-240	
32445665-0	2020	Role of Cbp, p300 and Akt in valproic acid induced neural tube defects in CD-1 mouse embryos.	Valproic Acid	29-42	E1A binding protein p300	Mus musculus	13-17	
32445665-12	2020	Downregulated expression of Cbp, p300, and Akt may play a key role in VPA-induced neural tube defects considering their vitally important role in embryonic development.	Valproic Acid	70-73	E1A binding protein p300	Mus musculus	33-37